Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 26, 2015 6:28 PM ET


Company Overview of Onyx Pharmaceuticals, Inc.

Executive Profile

Michael G. Kauffman M.D., Ph.D.

Co-Founder, Chief Executive Officer and Director, Karyopharm Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Michael G. Kauffman, M.D., Ph.D., co-founded Karyopharm Therapeutics, Inc. in 2008 and has been its Chief Executive Officer since January 5, 2011, Dr. Kauffman served as President at Karyopharm Therapeutics, Inc. from January 2011 to December 2013 and Chief Medical Officer since December 2012 until December 2013. Dr. Kauffman serves as President of OutlineMed Inc. He served as the Consultant of Onyx Pharmaceuticals, Inc. since December 31, 2010. He served as Clinical ...

Corporate Headquarters

249 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-266-0000
Fax: 650-266-0100

Board Members Memberships

Chief Medical Officer
Former Director
Former Chief Executive Officer, President and Director
Former Director, Chairman of Compensation Committee and Member of Audit Committee
Former Chief Executive Officer and Director
Independent Director, Member of Audit Committee and Member of Compensation Committee
Co-Founder, Chief Executive Officer and Director
Director, Member of Compensation Committee and Member of Audit Committee


Post-Doctoral Training
Harvard University
Johns Hopkins University
Johns Hopkins University
Amherst College

Other Affiliations

Annual Compensation

Total Annual Compensation$380,507

Stocks Options

All Other Compensation$12,739
Exercisable Options$33,712
Exercisable Options Value$763,914
Unexercisable Options$662,348
Unexercisable Options Value$9,679,845
Total Value of Options$10,443,759
Total Number of Options$696,060

Total Compensation

Total Annual Cash Compensation$563,246
Total Short Term Compensation$380,507
Other Long Term Compensation$12,739
Total Calculated Compensation$7,335,194

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Onyx Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at